WO2011067758A3 - Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae - Google Patents

Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae Download PDF

Info

Publication number
WO2011067758A3
WO2011067758A3 PCT/IL2010/001009 IL2010001009W WO2011067758A3 WO 2011067758 A3 WO2011067758 A3 WO 2011067758A3 IL 2010001009 W IL2010001009 W IL 2010001009W WO 2011067758 A3 WO2011067758 A3 WO 2011067758A3
Authority
WO
WIPO (PCT)
Prior art keywords
multimers
streptococcus pneumoniae
immunogenic fragments
pneumoniae proteins
pneumoniae
Prior art date
Application number
PCT/IL2010/001009
Other languages
English (en)
Other versions
WO2011067758A2 (fr
Inventor
Yaffa Mizrachi-Nebenzahl
Michael Tal
Ron Dagan
Maxim Portnoi
Original Assignee
Protea Vaccine Technologies Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protea Vaccine Technologies Ltd. filed Critical Protea Vaccine Technologies Ltd.
Publication of WO2011067758A2 publication Critical patent/WO2011067758A2/fr
Publication of WO2011067758A3 publication Critical patent/WO2011067758A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des fragments immunogènes, y compris des variantes et des analogues dérivés de protéines de Streptococcus pneumoniae (S. pneumoniae), des multimères de polypeptides et des protéines de fusion comprenant de tels polypeptides, et des vaccins comprenant de telles entités immunogènes. L'invention concerne notamment l'utilisation de tels vaccins pour provoquer une immunité protectrice contre S. pneumoniae.
PCT/IL2010/001009 2009-12-02 2010-12-01 Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae WO2011067758A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26577209P 2009-12-02 2009-12-02
US61/265,772 2009-12-02

Publications (2)

Publication Number Publication Date
WO2011067758A2 WO2011067758A2 (fr) 2011-06-09
WO2011067758A3 true WO2011067758A3 (fr) 2011-10-13

Family

ID=43983528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2010/001009 WO2011067758A2 (fr) 2009-12-02 2010-12-01 Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae

Country Status (1)

Country Link
WO (1) WO2011067758A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010273708B2 (en) 2009-06-29 2015-10-01 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
EP2665490B1 (fr) 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccins et compositions contre streptococcus pneumoniae
EP2955194A1 (fr) * 2014-06-12 2015-12-16 Universidade do Porto - Reitoria Vaccin néonatal
KR20170018920A (ko) 2014-06-12 2017-02-20 우니베르시다데 도 포르토 - 레이토리아 면역약화된 숙주용 백신
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077021A2 (fr) * 2001-03-27 2002-10-03 Chiron Srl. Proteines et acides nucleiques de streptococcus pneumoniae
US20050187718A1 (en) * 2001-09-21 2005-08-25 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from Streptococcus pneumoniae

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767842A (en) 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5093318A (en) 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA2017507C (fr) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant constitue d'une emulsion de gouttelettes submicron d'huile
US5709879A (en) 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
SK279188B6 (sk) 1992-06-25 1998-07-08 Smithkline Beecham Biologicals S.A. Vakcínová kompozícia spôsob jej prípravy a použiti
US5736146A (en) 1992-07-30 1998-04-07 Yeda Research And Development Co. Ltd. Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
WO1994021292A1 (fr) 1993-03-23 1994-09-29 Smithkline Beecham Biologicals (S.A.) Compositions vaccinales renfermant le lipide a monophosphorylique 3-o desacetyle
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5869058A (en) 1994-05-25 1999-02-09 Yeda Research And Development Co. Ltd. Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
ATE328890T1 (de) 1994-07-15 2006-06-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
RS50101B (sr) 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
US6355257B1 (en) 1997-05-08 2002-03-12 Corixa Corporation Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US7063967B2 (en) 1997-05-08 2006-06-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
AU732856B2 (en) 1997-05-20 2001-05-03 Galenica Pharmaceuticals, Inc. Triterpene saponin analogs having adjuvant and immunostimulatory activity
AU1145699A (en) 1997-09-05 1999-03-22 Smithkline Beecham Biologicals (Sa) Oil in water emulsions containing saponins
WO1999030737A1 (fr) 1997-12-16 1999-06-24 Chiron Corporation Utilisation de microparticules combinees avec des emulsions huile-dans-eau submicroniques
KR20010012186A (ko) 1998-03-04 2001-02-15 요트.게.아. 롤페즈 디스플레이 장치
CN1296416A (zh) 1998-04-09 2001-05-23 史密丝克莱恩比彻姆生物有限公司 佐剂组合物
KR100682154B1 (ko) 1998-05-07 2007-02-12 코릭사 코포레이션 아쥬번트 조성물 및 그의 사용방법
DE59911738D1 (de) 1998-12-14 2005-04-14 Deutsches Krebsforsch Verfahren und vorrichtung zum aufbringen von substanzen auf einen träger, insbesondere von monomeren für die kombinatorische synthese von molekülbibliotheken
US6843781B2 (en) 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
IL164242A0 (en) 2002-04-02 2005-12-18 Univ Ben Gurion Protein-based streptococcus pneumoniae vaccines
US7108679B2 (en) 2004-03-11 2006-09-19 Becton, Dickinson And Company Intradermal syringe and needle assembly
ES2539818T3 (es) 2007-08-02 2015-07-06 Biondvax Pharmaceuticals Ltd. Vacunas contra la gripe multiepitópicas multiméricas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077021A2 (fr) * 2001-03-27 2002-10-03 Chiron Srl. Proteines et acides nucleiques de streptococcus pneumoniae
US20050187718A1 (en) * 2001-09-21 2005-08-25 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from Streptococcus pneumoniae

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALONSODEVELASCO E ET AL: "STREPTOCOCCUS PNEUMONIAE: VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES", MICROBIOLOGICAL REVIEWS, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 59, no. 4, 1 December 1995 (1995-12-01), pages 591 - 603, XP000946788, ISSN: 0146-0749 *

Also Published As

Publication number Publication date
WO2011067758A2 (fr) 2011-06-09

Similar Documents

Publication Publication Date Title
WO2009016639A3 (fr) Vaccins contre la grippe à multiples épitopes multimères
CA2830786C (fr) Proteines de fusion et polyvaccins comprenant la proteine e et la piline a d'haemophilus influenzae
IL263249B (en) A polypeptide isolated from btv virus which causes an immune response in an animal and a polypeptide containing a DNA segment that codes for an epitope or an antigenic determinant of the btv polypeptide
WO2010150242A3 (fr) Peptides de streptococcus pneumoniae immunogènes et multimères peptidiques
WO2012069655A3 (fr) Modules de coiffage n-terminal améliorés pour des protéines de répétitions d'ankyrine conçues
WO2011067758A3 (fr) Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae
WO2011008974A3 (fr) Compositions à base de protéine f du vrs et procédés de fabrication associés
WO2011032161A8 (fr) Vaccins dirigés contre les cellules de langerhans
ZA201200832B (en) Immunogenic composition comprising antigenic s. aureus proteins
WO2010149752A3 (fr) Nouvelles compositions
MX2009001778A (es) Peptidos pcpa inmunogenicos y usos de los mismos.
MX346245B (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
WO2008124646A3 (fr) Utilisation de protéines amyloïdes en tant qu'échafaudages pour des vaccins
WO2010039224A3 (fr) Séquences du virus syncytial respiratoire (rsv) destinées à l'expression de protéines et aux vaccins
WO2007115059A3 (fr) Vaccin anti-streptocoques
WO2015063611A3 (fr) Variants d'albumine et utilisations de ceux-ci
WO2010019262A3 (fr) Vaccin polyvalent
MX344103B (es) Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
NZ703597A (en) Mutant fragments of ospa and methods and uses relating thereto
BR112015014727B8 (pt) Composição imunogênica, vacina, e, uso de uma composição imunogênica
WO2008134643A3 (fr) Antigènes de trypanosome, compositions de vaccins et procédés associés
IL232867B (en) Amyloid-binding polypeptide and chimeric protein containing it, pharmaceutical preparations containing the polypeptide or chimeric protein, methods for their preparation and uses
MX366178B (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
WO2015031778A3 (fr) Compositions et méthodes pour le traitement ou la prévention de la tuberculose
WO2012047267A3 (fr) Immunogène polyvalent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10801465

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10801465

Country of ref document: EP

Kind code of ref document: A2